A solid R&D platform is the foundation of a successful pharmaceutical program. Government and industry clients at all stages of the drug discovery cycle turn to SRI Biosciences to rapidly identify and optimize new drug leads and move them toward preclinical development.
SRI Biosciences applies its more than 50 years of experience to solve challenges in formulation, drug delivery development, and the characterization of small molecule drugs and biologics.
SRI's approach to drug formulation is customized to the needs of clients and partners. Services range from the preparation of dose formulations for preclinical in vitro and in vivo safety studies, to the design of finished product dosage forms for clinical trials.
SRI also provides pharmaceutical R&D support and services in these areas:
- Drug discovery
- Chemistry, manufacturing, and controls
- Combinatorial chemistry
- Custom drug formulations
- Immunology and inflammation
- Medicinal chemistry
- Pharmaceutical sciences
- Preclinical development planning and regulatory services
- Toxicology and metabolism
Our pharmaceutical R&D services meet worldwide stringent regulatory requirements. SRI studies are conducted under current Good Laboratory Practice (GLP) and Good Manufacturing Practice (cGMP) regulations.
Partnering to Rapidly Advance ZMapp® for Ebola Treatment
Innovative Science Overcomes Formulation Challenges
Partnering to Advance Therapy for Radiation Exposure
Vitamin A deficiency causes susceptibility — especially in children — to diarrhea-causing infections, which lead to millions of deaths each year. SRI is developing a probiotic that produces the vitamin.